Single versus combination pneumococcal conjugate vaccines (13PCV and PHiD-CV) for high-risk Aboriginal children (COMBO)

Leach, Amanda (Principal Investigator/Chief Investigator A)
Andrews, Ross (Associate Investigator)
Carapetis, Jonathan (Associate Investigator)
Krause, Vicki (Associate Investigator)
MULHOLLAND, Edward (Kim) (Co Investigator/Chief Investigator B)
Mcdonnell, Joseph (Associate Investigator)
Morris, Peter (Associate Investigator)
SANTOSHAM, Mathuram (Chief Investigator C)
Torzillo, Paul (Chief Investigator D)
Brown, Ngiare (Chief Investigator E)
McIntyre, Peter (Chief Investigator F)
Smith-Vaughan, Heidi (Chief Investigator G)
Skull, Susan Anne (Chief Investigator H)
Balloch, Anne (Chief Investigator I)
Wong, Jennifer (Project Manager)

Project: Research

Description

COMBO

Status	Finished
Effective start/end date	1/01/10 → 31/12/15

Pneumococcal conjugate vaccines PREVenar13 and SynflorIX in sequence or alone in high-risk Indigenous infants (PREV-IX_COMBO): Protocol of a randomised controlled trial
Leach, A., MULHOLLAND, E., Santosham, M., Torzillo, P., Brown, N., McIntyre, P., Smith-Vaughan, H., Skull, S., Balloch, A., Andrews, R., Carapetis, J., McDonnell, J., Krause, V. & Morris, P., Jan 2015, In: BMJ Open. 5, 1, p. 1-10 10 p., e007247.
Research output: Contribution to journal › Comment/debate

Open Access
File
20 Link opens in a new tab Citations (Scopus)

77 Downloads (Pure)